95 related articles for article (PubMed ID: 19442656)
1. Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells.
Matsunaga T; Arakaki M; Kamiya T; Endo S; El-Kabbani O; Hara A
Chem Biol Interact; 2009 Sep; 181(1):52-60. PubMed ID: 19442656
[TBL] [Abstract][Full Text] [Related]
2. Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activities.
Hendriks CM; Penning TM; Zang T; Wiemuth D; Gründer S; Sanhueza IA; Schoenebeck F; Bolm C
Bioorg Med Chem Lett; 2015 Oct; 25(20):4437-40. PubMed ID: 26372652
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer.
Pippione AC; Kovachka S; Vigato C; Bertarini L; Mannella I; Sainas S; Rolando B; Denasio E; Piercy-Mycock H; Romalho L; Salladini E; Adinolfi S; Zonari D; Peraldo-Neia C; Chiorino G; Passoni A; Mirza OA; Frydenvang K; Pors K; Lolli ML; Spyrakis F; Oliaro-Bosso S; Boschi D
Eur J Med Chem; 2024 Mar; 268():116193. PubMed ID: 38364714
[TBL] [Abstract][Full Text] [Related]
4. AKR1C3 as a target in castrate resistant prostate cancer.
Adeniji AO; Chen M; Penning TM
J Steroid Biochem Mol Biol; 2013 Sep; 137():136-49. PubMed ID: 23748150
[TBL] [Abstract][Full Text] [Related]
5. The aldo-keto reductases (AKRs): Overview.
Penning TM
Chem Biol Interact; 2015 Jun; 234():236-46. PubMed ID: 25304492
[TBL] [Abstract][Full Text] [Related]
6. 9,10-Phenanthrenequinone promotes secretion of pulmonary aldo-keto reductases with surfactant.
Matsunaga T; Haga M; Watanabe G; Shinoda Y; Endo S; Kajiwara Y; Tanaka H; Inagaki N; El-Kabbani O; Hara A
Cell Tissue Res; 2012 Feb; 347(2):407-17. PubMed ID: 22281686
[TBL] [Abstract][Full Text] [Related]
7. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation.
Sun SQ; Gu X; Gao XS; Li Y; Yu H; Xiong W; Yu H; Wang W; Li Y; Teng Y; Zhou D
Oncotarget; 2016 Jul; 7(30):48050-48058. PubMed ID: 27385003
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and structural evidence for a sequential ordered Bi Bi mechanism of catalysis by Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase.
Rudnick DA; McWherter CA; Rocque WJ; Lennon PJ; Getman DP; Gordon JI
J Biol Chem; 1991 May; 266(15):9732-9. PubMed ID: 2033063
[TBL] [Abstract][Full Text] [Related]
10. Aldo-keto reductase (AKR) superfamily: genomics and annotation.
Mindnich RD; Penning TM
Hum Genomics; 2009 Jul; 3(4):362-70. PubMed ID: 19706366
[TBL] [Abstract][Full Text] [Related]
11. 9,10-phenanthrenequinone induces monocytic differentiation of U937 cells through regulating expression of aldo-keto reductase 1C3.
Matsunaga T; Hosogai M; Arakaki M; Endo S; El-Kabbani O; Hara A
Biol Pharm Bull; 2012; 35(9):1598-602. PubMed ID: 22975515
[TBL] [Abstract][Full Text] [Related]
12. Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review.
Penning TM
Expert Opin Ther Pat; 2017 Dec; 27(12):1329-1340. PubMed ID: 28895472
[TBL] [Abstract][Full Text] [Related]
13. Break-induced telomere synthesis underlies alternative telomere maintenance.
Dilley RL; Verma P; Cho NW; Winters HD; Wondisford AR; Greenberg RA
Nature; 2016 Nov; 539(7627):54-58. PubMed ID: 27760120
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3.
Flanagan JU; Yosaatmadja Y; Teague RM; Chai MZ; Turnbull AP; Squire CJ
PLoS One; 2012; 7(8):e43965. PubMed ID: 22937138
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.
Byrns MC; Jin Y; Penning TM
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):95-104. PubMed ID: 21087665
[TBL] [Abstract][Full Text] [Related]
16. Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily.
Ruiz FX; Porté S; Gallego O; Moro A; Ardèvol A; Del Río-Espínola A; Rovira C; Farrés J; Parés X
Biochem J; 2011 Dec; 440(3):335-44. PubMed ID: 21851338
[TBL] [Abstract][Full Text] [Related]
17. The unusual mycobacterial chaperonins: evidence for in vivo oligomerization and specialization of function.
Fan M; Rao T; Zacco E; Ahmed MT; Shukla A; Ojha A; Freeke J; Robinson CV; Benesch JL; Lund PA
Mol Microbiol; 2012 Sep; 85(5):934-44. PubMed ID: 22834700
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.
Doig CL; Battaglia S; Khanim FL; Bunce CM; Campbell MJ
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):47-55. PubMed ID: 26429394
[TBL] [Abstract][Full Text] [Related]
19. Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer.
Hamid AR; Pfeiffer MJ; Verhaegh GW; Schaafsma E; Brandt A; Sweep FC; Sedelaar JP; Schalken JA
Mol Med; 2013 Jan; 18(1):1449-55. PubMed ID: 23196782
[TBL] [Abstract][Full Text] [Related]
20. DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Henson JD; Cao Y; Huschtscha LI; Chang AC; Au AY; Pickett HA; Reddel RR
Nat Biotechnol; 2009 Dec; 27(12):1181-5. PubMed ID: 19935656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]